ER-negative Breast Cancer
4 clinical trials · Condition
◉ Watch ER-negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade (NCT04675827) | Jules Bordet Institute | 2022-01-17 |
| A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) (NCT04504916) | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2020-10-07 |
| Sacituzumab Govitecan In TNBC (NCT04230109) | Massachusetts General Hospital | 2020-07-14 |
Track ER-negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.